ruthenium has been researched along with tetramethylammonium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aitken, JB; Antony, S; Brown, T; Harris, HH; Lai, B; Spiccia, L; Vogt, S | 1 |
1 other study(ies) available for ruthenium and tetramethylammonium
| Article | Year |
|---|---|
X-ray fluorescence imaging of single human cancer cells reveals that the N-heterocyclic ligands of iodinated analogues of ruthenium anticancer drugs remain coordinated after cellular uptake.
Topics: Antineoplastic Agents; Biological Transport; Cell Adhesion; Cell Line, Tumor; Heterocyclic Compounds; Humans; Iodine; Ligands; Neoplasms; Optical Imaging; Organometallic Compounds; Quaternary Ammonium Compounds; Ruthenium; Single-Cell Analysis; X-Rays | 2013 |